What You’ll Do
You will report to the VP, Head of Market Access, International and work closely with Market Access, Medical Affairs, Commercial International, and Launch Excellence colleagues across BridgeBio’s international markets, to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients globally.
Your primary purpose will be to lead the international HEOR strategy, generating and leveraging health economic and outcomes research evidence to secure timely, sustainable patient access to the company’s products. This includes oversight of HTA submissions, value dossiers, and real-world evidence studies across multiple international markets. In this role you ensure alignment of HEOR priorities with clinical value, launch timelines, and market access strategy.
You will also be a core member of the International Market Access team, contributing HEOR and evidence-generation expertise to global decision-making and ensuring alignment across regions while representing diverse market perspectives.
This role requires strong collaboration with cross-functional colleagues and external stakeholders across multiple countries to ensure high-quality execution and impact. The ideal candidate combines deep expertise in health economics and outcomes research across several international markets and experience supporting the introduction of innovative therapies in a global biotech environment. You are eager to make a meaningful contribution in pre-launch and launch phases, particularly within rare diseases and orphan conditions, and bring strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.
Responsibilities
- Define and lead the international HEOR strategy, ensuring alignment with market access and launch objectives across BridgeBio's therapeutic areas
- Design and oversee non-interventional studies, including registries and real-world evidence generation, from protocol development through publication
- Lead early payer engagement with key HTA/payer bodies (e.g. NICE UK, G-BA Germany, HAS France) to inform evidence generation strategy and reimbursement dossier development
- Closely collaborate with Market Access, Medical Affairs, and Commercial colleagues to ensure value and access optimization across international launches
- Provide health economic modeling and outcomes research expertise to support pricing and reimbursement strategy
- Manage external vendors, budgets, and contracts for HEOR studies, ensuring rigorous project management across competing deadlines